Northwestern Mutual Investment Management Company’s BioMarin Pharmaceuticals BMRN Stock Holding History

Northwestern Mutual Investment Management Company’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.49M	Buy	43,479 +439	+1%	+$24K	0.03%	259
2026 Q1	$2.43M	Buy	43,040 +58	+0.1%	+$3.38K	0.04%	237
2025 Q4	$2.55M	Buy	42,982 +183	+0.4%	+$9.96K	0.03%	217
2025 Q3	$2.32M	Sell	42,799 -19	-0%	-$1.09K	0.03%	242
2025 Q2	$2.35M	Buy	42,818 +443	+1%	+$26.1K	0.04%	220
2025 Q1	$3M	Buy	42,375 +19	+0%	+$1.28K	0.05%	132
2024 Q4	$2.78M	Buy	42,356 +118	+0.3%	+$7.9K	0.06%	149
2024 Q3	$2.97M	Sell	42,238 -141	-0.3%	-$11.8K	0.07%	144
2024 Q2	$3.49M	Buy	+42,379	New	+$3.53M	0.09%	99
2016 Q1	–	Sell	-18,928	Closed	-$1.98M	–	923
2015 Q4	$1.98M	Buy	18,928 +58	+0.3%	+$6.06K	0.04%	221
2015 Q3	$1.99M	Hold	18,870	–	–	0.04%	223
2015 Q2	$2.58M	Buy	18,870 +1,480	+9%	+$183K	0.05%	207
2015 Q1	$2.17M	Buy	+17,390	New	+$1.84M	0.04%	247

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return

Northwestern Mutual Investment Management Company's BMRN Position: Q2 2026 in Review

Northwestern Mutual Investment Management Company increased its BioMarin Pharmaceuticals (BMRN) stake by 1% in Q2 2026, buying an estimated $24K and bringing the position to 43,479 shares worth $2.49M. The position accounts for 0.03% of the portfolio, ranked #259.

Northwestern Mutual Investment Management Company first reported a position in BMRN in Q1 2015 and has held it in 13 quarters since. The position peaked at $3.49M in Q2 2024. 352 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Northwestern Mutual Investment Management Company held 43,479 shares of BioMarin Pharmaceuticals worth $2.49M as of Q2 2026.
Northwestern Mutual Investment Management Company bought 439 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $24K.
BioMarin Pharmaceuticals made up 0.03% of Northwestern Mutual Investment Management Company's portfolio in Q2 2026, its #259 holding.
Northwestern Mutual Investment Management Company first reported a position in BioMarin Pharmaceuticals in Q1 2015 and has held it in 13 quarters since.
Northwestern Mutual Investment Management Company's BioMarin Pharmaceuticals position peaked at $3.49M in Q2 2024.
352 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2026, filed 12 Aug 2026.